Literature DB >> 32945832

Nonfatal Opioid Overdoses at an Urban Emergency Department During the COVID-19 Pandemic.

Taylor A Ochalek1, Kirk L Cumpston2, Brandon K Wills2, Tamas S Gal3, F Gerard Moeller4.   

Abstract

Entities:  

Year:  2020        PMID： 32945832      PMCID： PMC7501586          DOI： 10.1001/jama.2020.17477

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  51 in total

1.  Changes in Outpatient Buprenorphine Dispensing During the COVID-19 Pandemic.

Authors:  Jessica Duncan Cance; Erin Doyle
Journal:  JAMA       Date:  2020-12-15       Impact factor: 56.272

2.  Treatment of Opioid Use Disorder Among Commercially Insured Patients in the Context of the COVID-19 Pandemic.

Authors:  Haiden A Huskamp; Alisa B Busch; Lori Uscher-Pines; Michael L Barnett; Lauren Riedel; Ateev Mehrotra
Journal:  JAMA       Date:  2020-12-15       Impact factor: 56.272

3.  Naloxone and Buprenorphine Prescribing Following US Emergency Department Visits for Suspected Opioid Overdose: August 2019 to April 2021.

Authors:  Kao-Ping Chua; Chin Hwa Y Dahlem; Thuy D Nguyen; Chad M Brummett; Rena M Conti; Amy S Bohnert; Aaron D Dora-Laskey; Keith E Kocher
Journal:  Ann Emerg Med       Date:  2021-11-19       Impact factor: 5.721

4.  Opioid use disorder and health service utilization among COVID-19 patients in the US: A nationwide cohort from the Cerner Real-World Data.

Authors:  Fares Qeadan; Benjamin Tingey; Rona Bern; Christina A Porucznik; Kevin English; Ali I Saeed; Erin Fanning Madden
Journal:  EClinicalMedicine       Date:  2021-06-04

5.  Research priorities for expanding access to methadone treatment for opioid use disorder in the United States: A National Institute on Drug Abuse Center for Clinical Trials Network Task Force report.

Authors:  Paul J Joudrey; Gavin Bart; Robert K Brooner; Lawrence Brown; Julie Dickson-Gomez; Adam Gordon; Sarah S Kawasaki; Jane M Liebschutz; Edward Nunes; Dennis McCarty; Robert P Schwartz; José Szapocnik; Madhukar Trivedi; Judith I Tsui; Arthur Williams; Li-Tzy Wu; David A Fiellin
Journal:  Subst Abus       Date:  2021       Impact factor: 3.716

6.  Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial.

Authors:  Li-Tzy Wu; William S John; Eric D Morse; Steve Adkins; Jennifer Pippin; Robert K Brooner; Robert P Schwartz
Journal:  Addiction       Date:  2021-08-16       Impact factor: 6.526

7.  Shifts in drug seizures in the United States during the COVID-19 pandemic.

Authors:  Joseph J Palamar; Austin Le; Thomas H Carr; Linda B Cottler
Journal:  Drug Alcohol Depend       Date:  2021-03-02       Impact factor: 4.492

8.  Evaluating the association between COVID-19 and psychiatric presentations, suicidal ideation in an emergency department.

Authors:  Michal J McDowell; Carrie E Fry; Mladen Nisavic; Mila Grossman; Charles Masaki; Emily Sorg; Suzanne Bird; Felicia Smith; Scott R Beach
Journal:  PLoS One       Date:  2021-06-30       Impact factor: 3.240

9.  Barriers and Motivators to Opioid Treatment Among Suburban Women Who Are Pregnant and Mothers in Caregiver Roles.

Authors:  Miriam Boeri; Aukje K Lamonica; Jeffrey M Turner; Amanda Parker; Grace Murphy; Carly Boccone
Journal:  Front Psychol       Date:  2021-07-01

10.  Media Exposure and Substance Use Increase during COVID-19.

Authors:  Ofer Amram; Porismita Borah; Deepika Kubsad; Sterling M McPherson
Journal:  Int J Environ Res Public Health       Date:  2021-06-11       Impact factor: 3.390
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.